Author: Kelly Kantor

Two peer-reviewed studies published in Obesity Pillars report that Ivim Health patients receiving GLP-1 therapy within a comprehensive care protocol achieved up to 26.54% average weight loss in real-world observational cohorts.

COLUMBUS, Ohio, March 12, 2026 /PRNewswire/ — Millions of patients are on GLP-1 medications. New peer-reviewed research shows that comprehensive clinical support is a decisive factor in achieving superior outcomes. Two peer-reviewed studies published in Obesity Pillars demonstrate that patients receiving GLP-1 therapy within a … Read more

online prescription weight loss center

Semaglutide vs Liraglutide

Liraglutide (the active ingredient in Saxenda®)[1] and semaglutide (the active ingredient in Wegovy® and Ozempic®)[2] are two GLP-1 receptor agonists used to manage type 2 diabetes. The primary difference between the two GLP-1 medications is the dosage … Read more